High energy electron beams shaped with applied magnetic fields could provide a competitive and cost‐effective alternative to proton and heavy‐ion radiotherapy by Becchetti, Frederick D. et al.
POINTÕCOUNTERPOINT
Suggestions for topics suitable for these Point/Counterpoint debates should be addressed to the Moderator: William R.
Hendee, Medical College of Wisconsin, Milwaukee: whendee@mcw.edu. Persons participating in Point/Counterpoint
discussions are selected for their knowledge and communicative skill. Their positions for or against a proposition may
or may not reflect their personal opinions or the positions of their employers.
High energy electron beams shaped with applied magnetic fields could
provide a competitive and cost-effective alternative to proton
and heavy-ion radiotherapy
Frederick D. Becchetti
Physics Department, University of Michigan, Ann Arbor, Michigan 48109
(Tel: 734/764-1598; E-mail: fdb@umich.edu)
Janet M. Sistersona)
Massachusetts General Hospital, Northeast Proton Therapy Center, Boston, Massachusetts 02114
(Tel: 617/724-1942; E-mail: jsisterson@partners.org)
William R. Hendee, Moderator
~Received 29 July 2002; accepted for publication 29 July 2002; published 30 September 2002!
@DOI: 10.1118/1.1510453#OVERVIEW
Work at several institutions has demonstrated that intense
magnetic fields can be used to confine and shape high-energy
electron beam-dose profiles. It is conceivable that this ap-
proach might compete effectively with hadron therapy. How-
ever, the technique gives rise to several technical challenges,
some of which may be insurmountable. Whether the tech-
nique has enough potential to be pursued as a possible ap-
proach for radiation therapy is the subject of this month’s
point/counterpoint debate.
Arguing for the Proposition is
Frederick D. Becchetti, Ph.D.
Dr. Becchetti has worked pri-
marily in accelerator-based
nuclear physics including the
application of large super-
conducting magnets to nuclear
reaction studies and recently,
application of the latter to ra-
diation oncology. He has
served on the Board of Editors
of Review of Scientific Instru-
ments ~1999–2001! and was
associate program chair for the recent Symposium on Radia-
tion Measurements and Applications held in Ann Arbor,
Michigan, May 21–23, 2002. Dr. Becchetti has chaired or
co-chaired a number of Ph.D. thesis committees dealing with
medical imaging, radiation oncology or related areas in
nuclear medicine.2435 Med. Phys. 29 10, October 2002 0094-2405Õ2002Õ29Arguing against the Proposi-
tion is Janet M. Sisterson,
Ph.D. Dr. Sisterson trained as a
Medical Physicist in London
following receipt of a Ph.D.
in high-energy physics from
the University of London. She
spent 25 years at the Harvard
Cyclotron Laboratory where
she helped develop many of
the techniques used worldwide
in proton radiation therapy. In
1998 she moved to the North-
east Proton Therapy Center, Department of Radiation On-
cology at the Massachusetts General Hospital. She holds a
joint appointment as Assistant Professor in the Department
of Radiation Oncology at Harvard Medical School. She is
the principal investigator on a NASA grant to measure
proton and neutron cross sections needed for cosmic-ray
studies.
FOR THE PROPOSITION: Frederick D. Becchetti,
Ph.D.
Opening Statement
Calculations1 and measurements using phantoms2,3 have
shown that the radiation dose profile from high-energy elec-
tron beams typically used in radiotherapy can be confined
using high ~viz., a few tesla! magnetic fields. The large pen-
umbra associated with scattering of electron beams in tissue-
like material is thereby greatly reduced. In addition, for mag-
netic fields parallel to the initial beam direction, additional,243510Õ2435Õ3Õ$19.00 © 2002 Am. Assoc. Phys. Med.
2436 Becchetti and Sisterson: PointÕCounterpoint 24363D focusing of the electron beam may be obtained. The net
effect is a greatly enhanced dose near the end of the elec-
trons’ range. The dose profile resembles a degraded Bragg
curve.2,3 This feature could be exploited in conformal radio-
therapy to furnish an alternative to proton or heavy-ion ra-
diotherapy, at least for certain types of tumors, and to pro-
vide an economical, on-site electron-beam therapy facility
for many hospitals. High-energy electron accelerators ~e.g.,
linacs and microtrons! and electron-beam gantries are afford-
able by many hospitals. This is in contrast to current proton
and heavy-ion radiotherapy units, which are large, costly fa-
cilities located far from most hospitals and hence not practi-
cal for widespread use, especially when fractionated doses
are needed. Many of the technical problems have been
solved, particularly the use and efficient operation of large-
bore superconducting magnets and such magnets are in rou-
tine use in MRI units at most large hospitals. Such magnets
can be designed, if needed, to allow rotation with a treatment
gantry.4 Recently mechanical coolers have been utilized
which can further simplify a gantry-mounted system, and
nonmagnetic treatment gantries and tables are feasible. Fur-
ther research and development appears warranted and if suc-
cessful could lead to animal and, eventually, human clinical
trials in the near future.
Rebuttal
It is not necessarily claimed that electrons confined by a
magnetic field are preferable to high-energy protons ~or
heavy ions! for many types of radiotherapy. Instead, as
noted, the high cost of high-energy ion accelerators, gantries,
radiation shielding and buildings has greatly limited the
number of patients that can be treated with protons. For some
patients, magnetically-confined electron-beam therapy may
in the future provide a viable alternative to protons at lower
cost. The experiments cited in Refs. 2 and 3 utilized a
hospital-based ‘‘table top’’ 50 MV electron racetrack mi-
crotron. 100 MV electron microtrons used for physics re-
search are similarly in operation. Providing an accurate 3D
focus for stereotactic treatment with electrons is perhaps the
major challenge. As noted in the opening statement, large-
bore superconducting magnets ~e.g., 1 m diam. bore31 m
long B>5T) are feasible, and can be gantry mounted. Such
magnets are presently used in research and industrial appli-
cations as well as in medical applications ~high-field MRI!.
Thus much of the needed engineering has already been done.
The key issue is to demonstrate that magnetically-confined
electron-beam radiotherapy may have advantages over other
modalities, even x-ray IMRT in certain circumstances.1–3,5
However, this issue can be addressed definitively only by
further research including realistic treatment simulations and
animal clinical trials.
AGAINST THE PROPOSITION: Janet M. Sisterson,
Ph.D.
Opening Statement
Computer simulations and some experiments show that
intense magnetic fields can be used to delineate the geometryMedical Physics, Vol. 29, No. 10, October 2002and control the dose distribution of high-energy electron
beams. For this reason, electron beams have been proposed
as a cost-effective alternative to heavy ion beams, with a
similar therapeutic benefit. Simulations and experiments
have been conducted in an attempt to overcome the inherent
limitations of electrons, all due to the small electron mass,
and to mimic, by external means, the inherent properties of
ion beams. The goal of these experiments has been to iden-
tify applications where electron beams can be equally or
preferentially used to treat specific tumor sites.
The inherent physical properties of ion beams are used to
advantage in radiation therapy. These properties include: ~1!
little penumbral scattering as the beam penetrates tissue; ~2!
a finite range in tissue, accurately controlled by the beam
energy; ~3! a very sharp fall-off in the distal edge of the dose
distribution; and ~4! a maximum rate of energy loss near the
end of range: ‘‘the Bragg peak effect.’’ These properties are
used to achieve dose distributions that are uniform over large
target volumes, with a sharp penumbra in all directions per-
pendicular to the beam and along the axis. The resulting dose
distributions conform closely to the target volumes, leading
to maximum sparing of adjacent normal tissues and sensitive
structures.
Electrons, as continuously ionizing particles, share some
of the properties of heavy ions. In electron beams, however,
the benefit of these properties is lost because of the extreme
scattering of individual electrons. Intense magnetic fields can
limit the scattering effects to a significant degree. Still, they
do not allow electrons to achieve the properties of an ion
beam Bragg peak or the dose distributions attainable by sum-
mation of such peaks. For example, the proposed magnetic
fields focus primarily in one dimension. This implies that any
magnetic focusing technique will require much more sophis-
ticated, three-dimensional control of the magnetic focus in-
side the patient. In addition, electron energies up to 100 MeV
may be needed to cover the full range of therapeutic appli-
cations. The construction of a device that delivers high-
energy electron beams with a precisely controlled three-
dimensional magnetic focusing lens may prove to be an
insurmountable, and certainly not cost-effective, engineering
task.
In contrast, intensity and energy modulated ion therapy is
already a reality, and permits precise control of dose deposi-
tion in volumes as large as 20 000 cm3 with a resolution of
0.125 cm3. The technology for delivering these fields is
proven and uses off-the-shelf magnetic devices and control
techniques. Field delivery is accurately controlled in both
time and space, a critical benefit when considering patient-
specific concerns such as organ motion.
In summary, one-dimensional magnetic control of elec-
tron fields may improve the therapeutic gain compared with
‘‘conventional’’ electron fields. Such control is no match for
intensity modulated x-ray therapy, conventional ion therapy,
or intensity modulated ion therapy. There is simply not a
clear rationale to justify pursuit of such a nontrivial and ex-
pensive engineering task as magnetic field-controlled elec-
tron beam therapy.
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Our colleague claims that electron beams, modified with
~strong! magnetic fields, can be delivered and controlled in a
clinical setting to produce therapeutic dose distributions that
might be an alternative to proton or heavy ion radiotherapy.
Such an alternative is deemed desirable due to the high cost
of a proton or ion facility, and the implied geographic sepa-
ration of such a facility from a hospital. We believe there are
several misconceptions in this position. First, the Harvard
Cyclotron Laboratory/Massachusetts General Hospital col-
laboration ~HCL!, with over 9,000 patients treated, shows
that fractionated proton radiotherapy can be successfully ac-
complished using a facility located about three miles from
the hospital campus. Second, it is true that proton and ion
therapy were pioneered at existing accelerator facilities, of-
ten under many constraints. However, there are currently
many hospital on-site proton centers treating patients, under
construction, or planned. Such facilities are expensive but
can still be cost-effective. For example, the cost of such a
facility is amortized over the 30-year lifetime of a cyclotron.
~Of note, the HCL operated for 50 years!! Over that lifetime,
a conventional clinic, albeit a large one, would purchase
about 12 linear accelerators comparable to the multiple treat-
ment rooms in a proton therapy facility. This analysis cer-Medical Physics, Vol. 29, No. 10, October 2002tainly reduces the gap in spending between a conventional
clinic and a clinic that also provides proton therapy. Finally,
we again stress that the predicted electron dose distributions
are not comparable to conventional, energy-modulated, pro-
ton Bragg peaks, and certainly not to intensity and energy
modulated proton beams or photon IMRT.
a!Dr. Sisterson’s section was written with the assistance of Hanne M. Kooy,
Ph.D., Associate Director Northeast Proton Therapy Center, Massachu-
setts General Hospital and Associate Professor, Department of Radiation
Oncology, Harvard Medical School, Boston, MA.
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